Research ArticleNeurology
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deussing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Irena Brzak, Ulf Neumann, Takashi Saito, Takaomi C. Saido, Peter Bartenstein, Axel Rominger, Jochen Herms and Matthias Brendel
Journal of Nuclear Medicine December 2019, 60 (12) 1787-1793; DOI: https://doi.org/10.2967/jnumed.119.227322
Christian Sacher
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Tanja Blume
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
2DZNE–German Center for Neurodegenerative Diseases, Munich, Germany
Leonie Beyer
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Finn Peters
2DZNE–German Center for Neurodegenerative Diseases, Munich, Germany
Florian Eckenweber
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Carmelo Sgobio
2DZNE–German Center for Neurodegenerative Diseases, Munich, Germany
Maximilian Deussing
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Nathalie L. Albert
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Marcus Unterrainer
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Simon Lindner
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Franz-Josef Gildehaus
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Barbara von Ungern-Sternberg
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Irena Brzak
3Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland
Ulf Neumann
3Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland
Takashi Saito
4Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama, Japan
Takaomi C. Saido
4Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama, Japan
Peter Bartenstein
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
Axel Rominger
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
6Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland; and
Jochen Herms
2DZNE–German Center for Neurodegenerative Diseases, Munich, Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
7Center of Neuropathology and Prion Research, University of Munich, Munich, Germany
Matthias Brendel
1Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deussing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Irena Brzak, Ulf Neumann, Takashi Saito, Takaomi C. Saido, Peter Bartenstein, Axel Rominger, Jochen Herms, Matthias Brendel
Journal of Nuclear Medicine Dec 2019, 60 (12) 1787-1793; DOI: 10.2967/jnumed.119.227322
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deussing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Irena Brzak, Ulf Neumann, Takashi Saito, Takaomi C. Saido, Peter Bartenstein, Axel Rominger, Jochen Herms, Matthias Brendel
Journal of Nuclear Medicine Dec 2019, 60 (12) 1787-1793; DOI: 10.2967/jnumed.119.227322
Jump to section
Related Articles
Cited By...
- Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimers disease
- 11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-{beta} After Therapeutic Intervention
- Glitter in the Darkness? Nonfibrillar {beta}-Amyloid Plaque Components Significantly Impact the {beta}-Amyloid PET Signal in Mouse Models of Alzheimer Disease
- MicroPET evidence for a hypersensitive neuroinflammatory profile of gp120 mouse model of HIV
- Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic Immunomodulation
- Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
- Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-{beta} Formation in a Transgenic Mouse Model of Alzheimers Disease: A Longitudinal in vivo Molecular Imaging Study